Hill-Rom Elects Stacy Enxing Seng to its Board of Directors

Announces Retirement of Joanne Smith from Hill-Rom Board

News provided by

Mar 04, 2015, 07:00 ET

CHICAGO, March 4, 2015 /PRNewswire/ -- Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that Stacy Enxing Seng has been elected to its Board of Directors. She most recently served as an Executive in Residence for Covidien, as well as President of Covidien's Vascular Therapies Division from 2012 to 2014, and President of Peripheral Vascular from 2010 to 2012.

Ms. Enxing Seng joined Covidien in 2010 through the $2.6B acquisition of ev3 Incorporated, where she was a founding member and executive officer responsible for leading ev3's Peripheral Vascular division from 2001 to 2010. Prior to that, she held positions of increasing responsibility with SCIMED, Boston Scientific, American Hospital Supply and Baxter.

"Stacy's experience in the medical device industry will be invaluable to Hill-Rom," said Rolf A. Classon, Chairman of the Hill-Rom Board of Directors. "Her background provides a broad range of managerial and operational experience that will serve our shareholders and Board extremely well."

Ms. Enxing Seng currently serves on the boards of Sonova Holding AG, Solace Therapeutics, and was formerly on the boards of FIRE 1 Medical Incubator and CV Ingenuity. She received a Master of Business Administration from Harvard University and has a Bachelor of Arts in Public Policy from Michigan State University.

Joanne Smith, M.D., is retiring from the Hill-Rom Board after 12 years of service. During that time, Dr. Smith has served numerous roles on the Board, including most recently as chairperson for the Nominating and Governance Committee and as a member of the Compensation and Management Development Committee. Dr. Smith is currently President and CEO of the Rehabilitation Institute of Chicago.

"We are deeply grateful and indebted to Joanne for her countless contributions and tireless dedication to Hill-Rom," said Chairman Classon. "Her guidance has helped our company achieve numerous significant milestones over the past 12 years, including the separation of Hill-Rom from Hillenbrand Industries and the acquisitions of Aspen Surgical, Liko, Trumpf Medical and Volker."

About Hill-Rom Holdings, Inc.
Hill-Rom is a leading global medical technology company with more than 7,000 employees worldwide. We partner with health care providers in more than 100 countries by focusing on patient care solutions that improve clinical and economic outcomes in five core areas: Advancing Mobility, Wound Care and Prevention, Clinical Workflow, Surgical Safety and Efficiency, and Respiratory Health. Around the world, Hill-Rom's people, products, and programs work towards one mission: Enhancing outcomes for patients and their caregivers.

www.hill-rom.com

Logo - http://photos.prnewswire.com/prnh/20130123/DE47178LOGO

SOURCE Hill-Rom Holdings, Inc.